__timestamp | Cytokinetics, Incorporated | Taro Pharmaceutical Industries Ltd. |
---|---|---|
Wednesday, January 1, 2014 | 17268000 | 91733000 |
Thursday, January 1, 2015 | 19667000 | 87644000 |
Friday, January 1, 2016 | 27823000 | 92365000 |
Sunday, January 1, 2017 | 36468000 | 85656000 |
Monday, January 1, 2018 | 31282000 | 88196000 |
Tuesday, January 1, 2019 | 39610000 | 89971000 |
Wednesday, January 1, 2020 | 52820000 | 93413000 |
Friday, January 1, 2021 | 96803000 | 91355000 |
Saturday, January 1, 2022 | 177977000 | 113676000 |
Sunday, January 1, 2023 | 173612000 | 198366000 |
Monday, January 1, 2024 | 218935000 |
Unlocking the unknown
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Cytokinetics, Incorporated and Taro Pharmaceutical Industries Ltd. over the past decade. From 2014 to 2023, Cytokinetics saw a staggering increase in SG&A expenses, peaking at nearly 178% of their 2014 levels by 2022. In contrast, Taro Pharmaceuticals maintained a more stable trajectory, with expenses rising by approximately 116% over the same period. Notably, in 2023, Taro's SG&A expenses surged to 198% of their 2014 figures, surpassing Cytokinetics. This trend highlights Taro's strategic shift towards increased operational spending. The data for 2024 is incomplete, but the existing trends provide valuable insights into the financial maneuvers of these industry giants.
Comparing SG&A Expenses: Novartis AG vs Cytokinetics, Incorporated Trends and Insights
Breaking Down SG&A Expenses: Viatris Inc. vs Cytokinetics, Incorporated
Summit Therapeutics Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Who Optimizes SG&A Costs Better? Cytokinetics, Incorporated or TG Therapeutics, Inc.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Breaking Down SG&A Expenses: Axsome Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: PTC Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? MorphoSys AG or Taro Pharmaceutical Industries Ltd.
Mesoblast Limited vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends